Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.
Identifieur interne : 000814 ( Main/Corpus ); précédent : 000813; suivant : 000815Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.
Auteurs : F. Magro ; J-F Rahier ; C. Abeu ; E. Macmahon ; A. Hart ; C J Van Der Woude ; H. Gordon ; M. Adamina ; N. Viget ; S. Vavricka ; T. Kucharzik ; S. Leone ; B. Siegmund ; S. Danese ; L. Peyrin-BirouletSource :
- Journal of Crohn's & colitis [ 1876-4479 ] ; 2020.
Abstract
Our knowledge on COVID-19 is changing and evolving rapidly, with novel insights and recommendations, almost on a daily basis. It behooves the medical community to provide updated information on a regular basis, on best practice to facilitate optimal care of infected patients and appropriate advice for the general population. This is particularly important in the case of patients with chronic conditions, such as Inflammatory Bowel Disease (IBD). In this paper, we compiled the existing evidence on the impact of COVID-19 in IBD patients and provide guidance and on the most appropriate care to adopt during the pandemic. Our review highlighted that IBD, per se, is not a risk factor for COVID-19. However, all IBD patients with symptoms should be tested for SARS-CoV-2 and the procedures for disease management shall be carefully adapted: i) in SARS-CoV-2 positive IBD patients, medical treatments should be re-evaluated (with particular focus on corticosteroids) always with the purpose of treating active disease and maintaining remission; ii) non-urgent surgeries and endoscopic procedures should be postponed for all patients; iii) online consultancy should be implemented; and iv) hospitalization and surgery should be limited to life threatening situations.
DOI: 10.1093/ecco-jcc/jjaa160
PubMed: 32722754
PubMed Central: PMC7454472
Links to Exploration step
pubmed:32722754Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.</title><author><name sortKey="Magro, F" sort="Magro, F" uniqKey="Magro F" first="F" last="Magro">F. Magro</name><affiliation><nlm:affiliation>Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal; Department of Gastroenterology, Centro Hospitalar de São João, Porto, Portugal;Department of Clinical Pharmacology Centro Hospitalar de São João, Porto, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Rahier, J F" sort="Rahier, J F" uniqKey="Rahier J" first="J-F" last="Rahier">J-F Rahier</name><affiliation><nlm:affiliation>CHU UCL Namur, Université catholique de Louvain, service de Hépato-gastroentérologie, Yvoir, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Abeu, C" sort="Abeu, C" uniqKey="Abeu C" first="C" last="Abeu">C. Abeu</name><affiliation><nlm:affiliation>Infectious Diseases Service, Centro Hospitalar Universitário São João, Porto, Portugal. Instituto de Inovação e Investigação em Saúde (I3s), Faculty of Medicine, Department of Medicine, University of Porto, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Macmahon, E" sort="Macmahon, E" uniqKey="Macmahon E" first="E" last="Macmahon">E. Macmahon</name><affiliation><nlm:affiliation>Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, U.K.</nlm:affiliation></affiliation></author><author><name sortKey="Hart, A" sort="Hart, A" uniqKey="Hart A" first="A" last="Hart">A. Hart</name><affiliation><nlm:affiliation>IBD Unit, St Mark's Hospital, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Van Der Woude, C J" sort="Van Der Woude, C J" uniqKey="Van Der Woude C" first="C J" last="Van Der Woude">C J Van Der Woude</name><affiliation><nlm:affiliation>Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlnads.</nlm:affiliation></affiliation></author><author><name sortKey="Gordon, H" sort="Gordon, H" uniqKey="Gordon H" first="H" last="Gordon">H. Gordon</name><affiliation><nlm:affiliation>Department of Gastroenterology Royal London Hospital, Barts Health NHS Trust, London, England. Centre for Immunobiology, The Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, England.</nlm:affiliation></affiliation></author><author><name sortKey="Adamina, M" sort="Adamina, M" uniqKey="Adamina M" first="M" last="Adamina">M. Adamina</name><affiliation><nlm:affiliation>Department of Surgery, Cantonal Hospital Winterthur, Winterthur, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Viget, N" sort="Viget, N" uniqKey="Viget N" first="N" last="Viget">N. Viget</name><affiliation><nlm:affiliation>Department of Infectious Diseases, Tourcoing Hospital, Tourcoing.</nlm:affiliation></affiliation></author><author><name sortKey="Vavricka, S" sort="Vavricka, S" uniqKey="Vavricka S" first="S" last="Vavricka">S. Vavricka</name><affiliation><nlm:affiliation>Center for Gastroenterology and Hepatology, Zürich, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Kucharzik, T" sort="Kucharzik, T" uniqKey="Kucharzik T" first="T" last="Kucharzik">T. Kucharzik</name><affiliation><nlm:affiliation>Lüneburg Hospital, University of Hamburg, Department of Gastroenterology, Lüneburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Leone, S" sort="Leone, S" uniqKey="Leone S" first="S" last="Leone">S. Leone</name><affiliation><nlm:affiliation>EFCCA, European Federation of Crohn's and Ulcerative Colitis Associations, Brussels, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Siegmund, B" sort="Siegmund, B" uniqKey="Siegmund B" first="B" last="Siegmund">B. Siegmund</name><affiliation><nlm:affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Danese, S" sort="Danese, S" uniqKey="Danese S" first="S" last="Danese">S. Danese</name><affiliation><nlm:affiliation>Division of Gastroenterology, IBD Center, Humanitas University, Rozzano, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Peyrin Biroulet, L" sort="Peyrin Biroulet, L" uniqKey="Peyrin Biroulet L" first="L" last="Peyrin-Biroulet">L. Peyrin-Biroulet</name><affiliation><nlm:affiliation>Department of Gastroenterology Nancy University Hospital, Vandoeuvre-Les-Nancy, France.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Inserm NGERE U1256, Lorraine University, Vandoeuvre-Les-Nancy, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32722754</idno><idno type="pmid">32722754</idno><idno type="doi">10.1093/ecco-jcc/jjaa160</idno><idno type="pmc">PMC7454472</idno><idno type="wicri:Area/Main/Corpus">000814</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000814</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.</title><author><name sortKey="Magro, F" sort="Magro, F" uniqKey="Magro F" first="F" last="Magro">F. Magro</name><affiliation><nlm:affiliation>Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal; Department of Gastroenterology, Centro Hospitalar de São João, Porto, Portugal;Department of Clinical Pharmacology Centro Hospitalar de São João, Porto, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Rahier, J F" sort="Rahier, J F" uniqKey="Rahier J" first="J-F" last="Rahier">J-F Rahier</name><affiliation><nlm:affiliation>CHU UCL Namur, Université catholique de Louvain, service de Hépato-gastroentérologie, Yvoir, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Abeu, C" sort="Abeu, C" uniqKey="Abeu C" first="C" last="Abeu">C. Abeu</name><affiliation><nlm:affiliation>Infectious Diseases Service, Centro Hospitalar Universitário São João, Porto, Portugal. Instituto de Inovação e Investigação em Saúde (I3s), Faculty of Medicine, Department of Medicine, University of Porto, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Macmahon, E" sort="Macmahon, E" uniqKey="Macmahon E" first="E" last="Macmahon">E. Macmahon</name><affiliation><nlm:affiliation>Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, U.K.</nlm:affiliation></affiliation></author><author><name sortKey="Hart, A" sort="Hart, A" uniqKey="Hart A" first="A" last="Hart">A. Hart</name><affiliation><nlm:affiliation>IBD Unit, St Mark's Hospital, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Van Der Woude, C J" sort="Van Der Woude, C J" uniqKey="Van Der Woude C" first="C J" last="Van Der Woude">C J Van Der Woude</name><affiliation><nlm:affiliation>Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlnads.</nlm:affiliation></affiliation></author><author><name sortKey="Gordon, H" sort="Gordon, H" uniqKey="Gordon H" first="H" last="Gordon">H. Gordon</name><affiliation><nlm:affiliation>Department of Gastroenterology Royal London Hospital, Barts Health NHS Trust, London, England. Centre for Immunobiology, The Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, England.</nlm:affiliation></affiliation></author><author><name sortKey="Adamina, M" sort="Adamina, M" uniqKey="Adamina M" first="M" last="Adamina">M. Adamina</name><affiliation><nlm:affiliation>Department of Surgery, Cantonal Hospital Winterthur, Winterthur, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Viget, N" sort="Viget, N" uniqKey="Viget N" first="N" last="Viget">N. Viget</name><affiliation><nlm:affiliation>Department of Infectious Diseases, Tourcoing Hospital, Tourcoing.</nlm:affiliation></affiliation></author><author><name sortKey="Vavricka, S" sort="Vavricka, S" uniqKey="Vavricka S" first="S" last="Vavricka">S. Vavricka</name><affiliation><nlm:affiliation>Center for Gastroenterology and Hepatology, Zürich, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Kucharzik, T" sort="Kucharzik, T" uniqKey="Kucharzik T" first="T" last="Kucharzik">T. Kucharzik</name><affiliation><nlm:affiliation>Lüneburg Hospital, University of Hamburg, Department of Gastroenterology, Lüneburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Leone, S" sort="Leone, S" uniqKey="Leone S" first="S" last="Leone">S. Leone</name><affiliation><nlm:affiliation>EFCCA, European Federation of Crohn's and Ulcerative Colitis Associations, Brussels, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Siegmund, B" sort="Siegmund, B" uniqKey="Siegmund B" first="B" last="Siegmund">B. Siegmund</name><affiliation><nlm:affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Danese, S" sort="Danese, S" uniqKey="Danese S" first="S" last="Danese">S. Danese</name><affiliation><nlm:affiliation>Division of Gastroenterology, IBD Center, Humanitas University, Rozzano, Milan, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Peyrin Biroulet, L" sort="Peyrin Biroulet, L" uniqKey="Peyrin Biroulet L" first="L" last="Peyrin-Biroulet">L. Peyrin-Biroulet</name><affiliation><nlm:affiliation>Department of Gastroenterology Nancy University Hospital, Vandoeuvre-Les-Nancy, France.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Inserm NGERE U1256, Lorraine University, Vandoeuvre-Les-Nancy, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of Crohn's & colitis</title><idno type="eISSN">1876-4479</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Our knowledge on COVID-19 is changing and evolving rapidly, with novel insights and recommendations, almost on a daily basis. It behooves the medical community to provide updated information on a regular basis, on best practice to facilitate optimal care of infected patients and appropriate advice for the general population. This is particularly important in the case of patients with chronic conditions, such as Inflammatory Bowel Disease (IBD). In this paper, we compiled the existing evidence on the impact of COVID-19 in IBD patients and provide guidance and on the most appropriate care to adopt during the pandemic. Our review highlighted that IBD, per se, is not a risk factor for COVID-19. However, all IBD patients with symptoms should be tested for SARS-CoV-2 and the procedures for disease management shall be carefully adapted: i) in SARS-CoV-2 positive IBD patients, medical treatments should be re-evaluated (with particular focus on corticosteroids) always with the purpose of treating active disease and maintaining remission; ii) non-urgent surgeries and endoscopic procedures should be postponed for all patients; iii) online consultancy should be implemented; and iv) hospitalization and surgery should be limited to life threatening situations.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32722754</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-4479</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of Crohn's & colitis</Title><ISOAbbreviation>J Crohns Colitis</ISOAbbreviation></Journal><ArticleTitle>Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jjaa160</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ecco-jcc/jjaa160</ELocationID><Abstract><AbstractText>Our knowledge on COVID-19 is changing and evolving rapidly, with novel insights and recommendations, almost on a daily basis. It behooves the medical community to provide updated information on a regular basis, on best practice to facilitate optimal care of infected patients and appropriate advice for the general population. This is particularly important in the case of patients with chronic conditions, such as Inflammatory Bowel Disease (IBD). In this paper, we compiled the existing evidence on the impact of COVID-19 in IBD patients and provide guidance and on the most appropriate care to adopt during the pandemic. Our review highlighted that IBD, per se, is not a risk factor for COVID-19. However, all IBD patients with symptoms should be tested for SARS-CoV-2 and the procedures for disease management shall be carefully adapted: i) in SARS-CoV-2 positive IBD patients, medical treatments should be re-evaluated (with particular focus on corticosteroids) always with the purpose of treating active disease and maintaining remission; ii) non-urgent surgeries and endoscopic procedures should be postponed for all patients; iii) online consultancy should be implemented; and iv) hospitalization and surgery should be limited to life threatening situations.</AbstractText><CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magro</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal; Department of Gastroenterology, Centro Hospitalar de São João, Porto, Portugal;Department of Clinical Pharmacology Centro Hospitalar de São João, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahier</LastName><ForeName>J-F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>CHU UCL Namur, Université catholique de Louvain, service de Hépato-gastroentérologie, Yvoir, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abeu</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases Service, Centro Hospitalar Universitário São João, Porto, Portugal. Instituto de Inovação e Investigação em Saúde (I3s), Faculty of Medicine, Department of Medicine, University of Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacMahon</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hart</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IBD Unit, St Mark's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Woude</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlnads.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology Royal London Hospital, Barts Health NHS Trust, London, England. Centre for Immunobiology, The Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamina</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cantonal Hospital Winterthur, Winterthur, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viget</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tourcoing Hospital, Tourcoing.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vavricka</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Gastroenterology and Hepatology, Zürich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucharzik</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lüneburg Hospital, University of Hamburg, Department of Gastroenterology, Lüneburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>EFCCA, European Federation of Crohn's and Ulcerative Colitis Associations, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegmund</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danese</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, IBD Center, Humanitas University, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyrin-Biroulet</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology Nancy University Hospital, Vandoeuvre-Les-Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inserm NGERE U1256, Lorraine University, Vandoeuvre-Les-Nancy, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Crohns Colitis</MedlineTA><NlmUniqueID>101318676</NlmUniqueID><ISSNLinking>1873-9946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32722754</ArticleId><ArticleId IdType="pii">5877458</ArticleId><ArticleId IdType="doi">10.1093/ecco-jcc/jjaa160</ArticleId><ArticleId IdType="pmc">PMC7454472</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000814 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000814 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32722754
|texte= Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32722754" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |